Presenters: David Maron, MD, and William Fearon, MD
Maron: Clinical Professor of Cardiovascular Medicine, Director of Preventive Cardiology
Fearon: Professor of Cardiovascular Medicine, Director of Interventional Cardiology
David Maron, MD
Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014.
William Fearon, MD
Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology and the Society of Cardiovascular Angiography and Interventions. He was elected to the American Society of Clinical Investigation.
Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and is a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He has presented and published a number of abstracts and peer-reviewed papers in this area, and serves on the editorial board of Circulation, the Journal of the American College of Cardiology, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He is the principal investigator on an R01 award from the NIH evaluating cardiac allograft vasculopathy. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement.